Want to track GMAB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Genmab A/S (GMAB) Statistics
Valuation metrics
Market Cap -
Enterprise value 19.22B
Trailing P/E (ttm) 18.75
Forward P/E -
PEG ratio -0.21
Price/Sales (ttm) 1.64
Price/Book (mrq) 2.71
Enterprise Value/Revenue 2.04
Enterprise Value/EBITDA 13.56
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 136.25K
Average volume (90 days) 155.12K
Price summary
52-Week low 1,275
52-Week high 2,257
Beta -
50-Day moving average 1,673.41
200-Day moving average 1,860.92
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.09%
Operating margin 0.14%
Operational effectiveness
Return on assets 0.07%
Return on equity 0.15%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 153.12
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 13.36
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 24.75
Total debt (mrq) -
Total Debt/Equity (mrq) 0.94
Current ratio (mrq) 2.18%
Book value per share (mrq) 92.47
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
